Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$6.71M Sell
23,563
-174
-0.7% -$51.8K 0.11% 181
2023
Q1
$6.81M Buy
23,737
+504
+2% +$139K 0.12% 161
2022
Q4
$6.43M Sell
23,233
-2,286
-9% -$646K 0.12% 161
2022
Q3
$6.81M Sell
25,519
-1,310
-5% -$278K 0.12% 137
2022
Q2
$5.47M Sell
26,829
-2,277
-8% -$465K 0.11% 171
2022
Q1
$6.13M Sell
29,106
-433
-1% -$94.2K 0.12% 165
2021
Q4
$7.09M Buy
29,539
+195
+0.7% +$50.1K 0.14% 151
2021
Q3
$8M Sell
29,344
-160
-0.5% -$52.4K 0.17% 130
2021
Q2
$10.6M Buy
29,504
+2,813
+11% +$852K 0.24% 109
2021
Q1
$7.47M Buy
26,691
+4,576
+21% +$1.23M 0.19% 126
2020
Q4
$5.92M Buy
22,115
+3,445
+18% +$889K 0.17% 132
2020
Q3
$5.3M Buy
18,670
+2,382
+15% +$664K 0.18% 124
2020
Q2
$4.36M Buy
16,288
+2,394
+17% +$720K 0.16% 119
2020
Q1
$4.4M Buy
13,894
+2,962
+27% +$899K 0.19% 87
2019
Q4
$3.24M Buy
10,932
+1,516
+16% +$421K 0.13% 118
2019
Q3
$2.19M Buy
9,416
+3,300
+54% +$768K 0.09% 115
2019
Q2
$1.43M Buy
6,116
+4,166
+214% +$962K 0.06% 115
2019
Q1
$461K Buy
+1,950
New +$614K 0.02% 123

Other funds holding BIIB

PFS Investments's BIIB Position: Q2 2023 in Review

PFS Investments reduced its Biogen (BIIB) stake by 0.73% in Q2 2023, selling an estimated $51.8K and leaving 23,563 shares worth $6.71M. The position accounts for 0.11% of the portfolio, ranked #181.

PFS Investments first reported a position in BIIB in Q1 2019 and has held it in 18 quarters since. The position peaked at $10.6M in Q2 2021. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.

  • PFS Investments held 23,563 shares of Biogen worth $6.71M as of Q2 2023.
  • PFS Investments sold 174 Biogen shares in Q2 2023, an estimated $51.8K.
  • Biogen made up 0.11% of PFS Investments's portfolio in Q2 2023, its #181 holding.
  • PFS Investments first reported a position in Biogen in Q1 2019 and has held it in 18 quarters since.
  • PFS Investments's Biogen position peaked at $10.6M in Q2 2021.
  • 1,008 funds tracked by Wall St. Rank held Biogen as of Q2 2023.

Based on PFS Investments's 13F filing for Q2 2023, filed 14 Aug 2023.